Back to search

Article

A novel ferronucleoside that targets DNA replication in pancreatic cancer cells

2021-07-22

Abstract excerpt

<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC) is a disease that remains largely refractory to existing treatments including the nucleoside analogue gemcitabine. In the current study we demonstrate that the ferronucleoside 1-(S,Rp) is cytotoxic in a panel of PDAC cell lines including gemcitabine resistant MIAPaCa2, with IC50 values comparable to cisplatin. Biochemical studies show that the mec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24b15bde-73fe-5213-b866-2e143bf8ae87
DOI
10.21203/rs.3.rs-741964/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel ferronucleoside that targets DNA replication in pancreatic cancer cellsDOI 10.21203/rs.3.rs-741964/v1
Select a neighboring publication to make it the new centre.